Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C2H2N2O |
| Molecular Weight | 70.0501 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O1C=NN=C1
InChI
InChIKey=FKASFBLJDCHBNZ-UHFFFAOYSA-N
InChI=1S/C2H2N2O/c1-3-4-2-5-1/h1-2H
| Molecular Formula | C2H2N2O |
| Molecular Weight | 70.0501 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Allosteric regulation of glycogen synthase kinase 3β: a theoretical study. | 2010-12-28 |
|
| Bromidotricarbon-yl[2-phenyl-5-(pyridin-2-yl-κN)-1,3,4-oxadiazole-κN]rhenium(I) dichloro-methane monosolvate. | 2010-12-18 |
|
| A two-photon excited luminescence of water-soluble rhodamine-platinum(II) complex: fluorescent probe specific for Hg2+ detection in live cell. | 2010-12-15 |
|
| Bromidotricarbon-yl[2-(pyridin-2-yl-κN)-5-p-tolyl-1,3,4-oxadiazole-κN]rhenium(I) dichloro-methane monosolvate. | 2010-12-04 |
|
| Synthesis, biological evaluation, and molecular docking studies of 2-chloropyridine derivatives possessing 1,3,4-oxadiazole moiety as potential antitumor agents. | 2010-11-15 |
|
| Synthesis and biological evaluation of some 1,3,4-oxadiazole derivatives. | 2010-11 |
|
| Design, synthesis and biological evaluation of 1,3,4-oxadiazole derivatives. | 2010-11 |
|
| Synthesis and pharmacological evaluation of condensed heterocyclic 6-substituted 1,2,4-triazolo-[3,4-b]-1,3,4-thiadiazole and 1,3,4-oxadiazole derivatives of isoniazid. | 2010-08-15 |
|
| New hyperbranched conjugated polymers containing hexaphenylbenzene and oxadiazole units: convenient synthesis and efficient deep blue emitters for PLEDs application. | 2010-07-22 |
|
| Efficient Electrochemical Synthesis, Antimicrobial and Antiinflammatory Activity of 2-amino-5-substituted- 1,3,4-oxadiazole Derivatives. | 2010-07 |
|
| QSAR study of substituted 1,3,4-oxadiazole naphthyridines as HIV-1 integrase inhibitors. | 2010-07 |
|
| A practical synthesis of 5-lipoxygenase inhibitor MK-0633. | 2010-06-18 |
|
| Novel one-pot, four-component condensation reaction: an efficient approach for the synthesis of 2,5-disubstituted 1,3,4-oxadiazole derivatives by a Ugi-4CR/aza-Wittig sequence. | 2010-06-18 |
|
| Synthesis of novel 1,3,4-oxadiazole derivatives as potential antimicrobial agents. | 2010-06-08 |
|
| Synthesis of a second generation chroman/catechol hybrids and evaluation of their activity in protecting neuronal cells from oxidative stress-induced cell death. | 2010-06-01 |
|
| 4-Chloro-N-[3-methyl-1-(5-thioxo-4,5-dihydro-1,3,4-oxadiazol-2-yl)but-yl]benzamide. | 2010-05-19 |
|
| Molecular logic gates and switches based on 1,3,4-oxadiazoles triggered by metal ions. | 2010-05-17 |
|
| Synthesis of some novel 2-substituted-5-[isopropylthiazole] clubbed 1,2,4-triazole and 1,3,4-oxadiazoles as potential antimicrobial and antitubercular agents. | 2010-05 |
|
| Novel derivatives of 1,3,4-oxadiazoles are potent mitostatic agents featuring strong microtubule depolymerizing activity in the sea urchin embryo and cell culture assays. | 2010-05 |
|
| Synthesis and anti-inflammatory evaluation of some condensed [4-(3,4-dimethylphenyl)-1(2H)-oxo-phthalazin-2-yl]acetic acid hydrazide. | 2010-04 |
|
| Asymmetric total synthesis of vindoline. | 2010-03-24 |
|
| Total synthesis of (+)-fendleridine (aspidoalbidine) and (+)-1-acetylaspidoalbidine. | 2010-03-10 |
|
| Synthesis, characterization and biological activity of some new 1,3,4-oxadiazole bearing 2-flouro-4-methoxy phenyl moiety. | 2010-03 |
|
| Anti-HIV activity of new substituted 1,3,4-oxadiazole derivatives and their acyclic nucleoside analogues. | 2010-02-18 |
|
| A possible correlation between the correction of endothelial dysfunction and normalization of high blood pressure levels by 1,3,4-oxadiazole derivative, an L-type Ca2+ channel blocker in deoxycorticosterone acetate and N(G)-nitro-l-arginine hypertensive rats. | 2010-01-27 |
|
| Synthesis and characterization of organic dyes containing various donors and acceptors. | 2010-01-22 |
|
| The modulation of electronic and optical properties of OXD-X through introduction of the electron-withdrawing groups: a DFT study. | 2010-01 |
|
| Synthesis and antimicrobial activity of 3-(1,3,4-Oxadiazol-2-yl)quinazolin-4(3H)-ones. | 2009-12-17 |
|
| 2-(4-tert-Butyl-phen-yl)-5-p-tolyl-1,3,4-oxadiazole. | 2009-12-04 |
|
| Vasorelaxant effect in rat aortic rings through calcium channel blockage: a preliminary in vitro assessment of a 1,3,4-oxadiazole derivative. | 2009-10-30 |
|
| 2-{3-[4-(Alkylsulfinyl)phenyl]-1-benzofuran-5-yl}-5-methyl-1,3,4-oxadiazole derivatives as novel inhibitors of glycogen synthase kinase-3beta with good brain permeability. | 2009-10-22 |
|
| Design, synthesis and hypolipidemic activity of novel 2-(naphthalen-2-yloxy)propionic acid derivatives as desmethyl fibrate analogs. | 2009-10 |
|
| Synthesis and pharmacological evaluation of 1,3,4-oxadiazole bearing bis(heterocycle) derivatives as anti-inflammatory and analgesic agents. | 2009-10 |
|
| Design and synthesis of novel neuroprotective 1,2-dithiolane/chroman hybrids. | 2009-09-01 |
|
| 5-[1-(3,4-Dichloro-phen-oxy)eth-yl]-1,3,4-oxadiazole-2(3H)-thione hemihydrate. | 2009-08-08 |
|
| Methylsulfonylpyrazolyl oxadiazoles and thiadiazoles as potent, orally bioavailable cannabinoid-1 receptor antagonists for the treatment of obesity. | 2009-08 |
|
| A new type of five-membered heterocyclic inhibitors of basic metallocarboxypeptidases. | 2009-08 |
|
| Synthesis of novel 1,3,4-oxadiazole derivatives and their biological properties. | 2009-06 |
|
| (2S)-Methyl 2-(4-chloro-benzene-sulfon-amido)-4-(methyl-sulfan-yl)butanoate. | 2009-05-20 |
|
| (2S)-Methyl 2-(p-toluenesulfonamido)propanoate. | 2009-05-14 |
|
| Luminescent, liquid crystalline tris(N-salicylideneaniline)s: synthesis and characterization. | 2009-04-17 |
|
| Raltegravir, elvitegravir, and metoogravir: the birth of "me-too" HIV-1 integrase inhibitors. | 2009-03-05 |
|
| N,N'-Diacetyl-N'-[(4-nitro-phen-oxy)acetyl]acetohydrazide. | 2009-01-23 |
|
| Synthesis and Biological Evaluation of beta-Aroylpropionic acid based 1,3,4-Oxadiazoles. | 2009-01 |
|
| N,N'-Dibenzyl-2,2'-[(1,3,4-oxadiazole-2,5-di-yl)bis-(o-phenyl-eneoxy)]diacet-amide. | 2008-10-31 |
|
| 1-[2-(3,4-Dichloro-phen-yl)-5-(3,4,5-trimethoxy-phen-yl)-2,3-dihydro-1,3,4-oxadiazol-3-yl]ethanone. | 2008-07-09 |
|
| Ethyl 2-(5-phenyl-1,3,4-oxadiazol-2-ylsulfan-yl)acetate. | 2008-03-20 |
|
| N,N-Dimethyl-4-[5-(5-methyl-1-phenyl-1H-pyrazol-4-yl)-1,3,4-oxadiazol-2-yl]aniline. | 2008-01-04 |
|
| Synthesis, Antimicrobial and Antiinflammatory Activity of 2,5-Disubstituted-1,3,4-oxadiazoles. | 2008-01 |
|
| N-Phenyl-N-{4-[5-(4-pyrid-yl)-1,3,4-oxadiazol-2-yl]phen-yl}aniline. | 2007-12-12 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 21:19:17 GMT 2025
by
admin
on
Mon Mar 31 21:19:17 GMT 2025
|
| Record UNII |
20O2F20OUR
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
1,3,4-Oxadiazole
Created by
admin on Mon Mar 31 21:19:17 GMT 2025 , Edited by admin on Mon Mar 31 21:19:17 GMT 2025
|
PRIMARY | |||
|
46810
Created by
admin on Mon Mar 31 21:19:17 GMT 2025 , Edited by admin on Mon Mar 31 21:19:17 GMT 2025
|
PRIMARY | |||
|
122449
Created by
admin on Mon Mar 31 21:19:17 GMT 2025 , Edited by admin on Mon Mar 31 21:19:17 GMT 2025
|
PRIMARY | |||
|
20O2F20OUR
Created by
admin on Mon Mar 31 21:19:17 GMT 2025 , Edited by admin on Mon Mar 31 21:19:17 GMT 2025
|
PRIMARY | |||
|
m8275
Created by
admin on Mon Mar 31 21:19:17 GMT 2025 , Edited by admin on Mon Mar 31 21:19:17 GMT 2025
|
PRIMARY | Merck Index | ||
|
DTXSID10182987
Created by
admin on Mon Mar 31 21:19:17 GMT 2025 , Edited by admin on Mon Mar 31 21:19:17 GMT 2025
|
PRIMARY | |||
|
288-99-3
Created by
admin on Mon Mar 31 21:19:17 GMT 2025 , Edited by admin on Mon Mar 31 21:19:17 GMT 2025
|
PRIMARY | |||
|
97428
Created by
admin on Mon Mar 31 21:19:17 GMT 2025 , Edited by admin on Mon Mar 31 21:19:17 GMT 2025
|
PRIMARY |